Searched for
COMMODITY GENERICS
Raghuram Rajan's warning to India after Hormuz shock: Build bigger oil reserves, diversify fasterGlobal economic shocks from trade disruptions and geopolitical tensions are reshaping resilience, according to Raghuram Rajan. He stresses ...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- Are mutual fund investors losing interest in gold ETFs and multi asset allocation funds?Gold ETFs and multi-asset allocation funds experienced a moderation in investor inflows last month, with gold ETFs seeing a net outflow of ...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- India Inc sails past fourth-quarter estimates, but oil shock clouds outlookIndian companies achieved better-than-expected profits in the March quarter. Domestic activity was strong, supported by tax cuts and easy m...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Buy, Sell or Hold: Citi maintains buy on Eicher Motors; Goldman Sachs retains buy on Max HealthcareBrokerages maintain a positive outlook on select large-cap pharmaceutical, automobile, and healthcare stocks, citing strong growth prospect...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Flex office: As GCCs boom, Table Space is betting big on managed workspacesAs India’s GCC ecosystem expands rapidly, enterprise managed workspace providers are emerging as critical enablers of global firms entering...
- Kalshi, Polymarket defy India ban on online betting platformsDespite India's technology ministry warning that prediction markets like Polymarket and Kalshi are illegal, customers in India continue to ...
- Why NMC's mandate for stopping branded generic prescriptions was uncalled forBranded generics also add significant value to the healthcare ecosystem. They develop and circulate patient education materials. In-patient...
- Life saviors force-feed pills bitter on pocket in exchange for exotic vacations, chic carsTo keep a gauge if a doctor is prescribing drugs manufactured by particular pharmaceutical companies, medical representatives collect weekl...
- Electronic industry given option to declare some mandatory details on package via QR codeThe additional mandatory declarations such as the address of the manufacturer or packer or importer, the common or generic name of the comm...
- Centre allows electronic products to declare information via QR codeThe Department of Consumer Affairs makes it mandatory for electronic products to declare certain mandatory declarations through the QR Code...
- MCX system to allow negative price bids from July 27The upgraded system follows the settlement of the generic crude contract at negative price months ago, which resulted in members long the c...
- Dr Reddy’s not as big as it should be in India...we want to grow more: GV PrasadHyderabad-based Dr Reddy's Laboratories sprung a surprise on Wednesday when it announced that it will acquire the domestic business of Wock...
- Hetero buy will boost Cipla's US ops in next 2-3 years; hold stock @ target of Rs 755: Praful Bohra, Religare"Cipla's portfolio is of a commodity generics type; so this will definitely place it in a strong position in terms of product pipeline in t...
- Prescribing generic drugs may become mustThe govt may make it mandatory for all doctors to write the generic or chemical name of drugs they prescribe, a move that can cut medicine ...
- Reliance, Mylan, Ranbaxy eye Shasun’s API businessMukesh Ambani's Reliance Pharma could vie with global giants Mylan and Ranbaxy in bidding for Shasun's Rs 400-crore API business. Bring hom...
- Ranbaxy, Jupiter Bioscience enter into marketing tie-upRanbaxy Laboratories is about to enter into a 10-year co-marketing agreement with Jupiter Bioscience to tap the $6-billion global peptide p...
Load More
